D008691Chemicals & DrugsD02.522.675120.999286Methadonecmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.1428720.1428721research area of0.3557580.1129855subject area forPhDDelwynCatleyDelwyn Catley0.000000000000000.0000000000000067Catley, Delwyn0000-0002-7270-8732Associate Director, Center for Children's Healthy Lifestyles & Nutrition16368658Richter KP, McCool RM, Catley D, Hall M, Ahluwalia JSJournal of addictive diseasesRichter KP, McCool RM, Catley D, Hall M, Ahluwalia JS. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. J Addict Dis. 2005; 24(4):79-90.J Addict Dis2005-01-01T00:00:002005Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.17469938Richter KP, Hamilton AK, Hall S, Catley D, Cox LS, Grobe JExperimental and clinical psychopharmacologyRichter KP, Hamilton AK, Hall S, Catley D, Cox LS, Grobe J. Patterns of smoking and methadone dose in drug treatment patients. Exp Clin Psychopharmacol. 2007 Apr; 15(2):144-53.Exp Clin Psychopharmacol2007-04-01T00:00:002007Patterns of smoking and methadone dose in drug treatment patients.10224975Bach PB, Lantos JAmerican journal of public healthBach PB, Lantos J. Methadone dosing, heroin affordability, and the severity of addiction. Am J Public Health. 1999 May; 89(5):662-5.Am J Public Health1999-05-01T00:00:001999Methadone dosing, heroin affordability, and the severity of addiction.PediatricsClinicalChildren's Mercy Kansas City19398463Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, Lewis TR, Yaster M, Gauda EBPediatricsAgthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, Lewis TR, Yaster M, Gauda EB. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009 May; 123(5):e849-56.Pediatrics2009-04-27T00:00:002009Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.23059064McLemore GL, Lewis T, Jones CH, Gauda EBSeminars in fetal & neonatal medicineMcLemore GL, Lewis T, Jones CH, Gauda EB. Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome. Semin Fetal Neonatal Med. 2013 Feb; 18(1):35-41.Semin Fetal Neonatal Med2012-10-09T00:00:002012Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.true1Associate Director, Center for Children's Healthy Lifestyles & NutritionAssociate Director, Center for Children's Healthy Lifestyles & Nutrition